이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

운동 유발성 역설성 성대 운동 시 호흡 및 실시간 역학 (EILO)

2026년 11월 4일 업데이트: Rita R. Patel, Indiana University

운동 유발성 역설적 성대 운동 시 호흡 및 실시간 역학

The overall objectives of the proposed research are to:

  1. Evaluate the diagnostic validity of a novel mechano-acoustic signatures of task-characteristic activity during symptomatic and asymptomatic breathing in Exercise-Induced Laryngeal Obstruction (EILO) patients with the use of a novel miniature, soft wearable skin-mounted device,
  2. Identify the mechanism/s of paradoxical respiratory control in EILO by quantifying the relationship between pulmonary mechanics, partial pressure of carbon dioxide (PCO2) maintenance, and vocal fold aperture prior to and during symptomatic and asymptomatic exercise ventilation, and
  3. Identify unique biophysiological factors contributing to EILO among exercisers with and without EILO. Findings will be highly novel and clinically significant for early identification and management of EILO.

The main study will enroll 60 participants with EILO and 60 without EILO to complete three separate visits:

  1. Exercise treadmill study
  2. Free running with the device on the neck
  3. Undergoing MRI (Magnetic Resonance Imaging) of the vocal tract.

연구 개요

상태

모병

정황

개입 / 치료

상세 설명

Main Study

At the first study visit, participants will sign informed consent, complete study questionnaires, have their height, weight, and body composition measured, and perform resting pulmonary function tests. Participants will then warm up on the treadmill for 10 minutes. An endoscope will be placed in one nostril until the vocal folds are visible, and subjects will be fitted with a chest strap heart rate monitor, an oro-nasal face mask, and the mechanoacoustic device. This sensor is placed on the neck with a velcro band. Participants will then undergo a graded exercise test during which a carbon-dioxide enriched gas mixture will be administered. The amount of the gas mixture will be titrated based on measures of the participant's breathing and lung function. This visit will be video recorded.

At the second study visit, participants will be asked to again wear the mechanoacoustic device while free running for 10 minutes in a large room or on a track. This visit will be video-recorded.

At the third study visit, participants will be asked to undergo an MRI scan, during which they will perform a variety of breathing exercises including rest breathing, rapid breathing, pursed lip breathing, sniff, and open mouth breathing. Research personnel will instruct participants in the various breathing techniques prior to the scan.

The study visits may occur in any order.

연구 유형

중재적

등록 (추정된)

120

단계

  • 2 단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

  • 이름: Rita R Patel
  • 전화번호: 812-855-3886
  • 이메일: patelrir@iu.edu

연구 장소

    • Indiana
      • Bloomington, Indiana, 미국, 47401
        • 모병
        • Indiana University
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria for Exercise-Induced Laryngeal Obstruction (EILO):

  • Physically active >2.5 hours per week
  • Patients with EILO, as diagnosed by routine clinical examination by physician and/or speech language pathologist
  • Age range of 18-26 years
  • Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise
  • Score of 7 or higher on the Dyspnea Index, which is a validated instrument to capture participant self-report of upper airway dyspnea symptoms.
  • Classified as low risk, based on the modified Physical Activity Readiness Questionnaire (PAR-Q) questionnaire, body mass index, and non-smoking status
  • Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.

Inclusion Criteria for Controls

  • Physically active >2.5 hours per week
  • Age range of 18-26 years
  • Classified as low risk, based on the modified PAR-Q questionnaire, body mass index, and non-smoking status
  • Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.

Exclusion Criteria for EILO:

  • Individuals older than 26 years and younger than 18 years of age.
  • Women who are pregnant or could possibly be pregnant.
  • A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
  • Current smoker
  • Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
  • Do not report the following: Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise

Exclusion Criteria for Controls

  • Individuals older than 26 years and younger than 18 years of age.
  • Women who are pregnant or could possibly be pregnant.
  • A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
  • Current smoker
  • Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
  • Significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위화되지 않음
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: EILO Participants

Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen))

A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles.

활성 비교기: Control Participants

Participants without Exercise-induced laryngeal obstruction (EILO).

Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen))

A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Device measurements from real time running
기간: Baseline and Periprocedural

Muscle activation of cricothyroid/sternohyoid muscle measured via customized surface electromyography amplifier

Baseline and Periprocedural
Device measurements from real time running
기간: Baseline and Periprocedural

Normalized amplitude (100% of maximum voluntary contraction) Burst duration (milliseconds) prior to and during Exercise-Induced Laryngeal Obstruction event of laryngeal closure.

Baseline and Periprocedural
Device measurements from real time running
기간: Baseline and Perioprocedural

Exercise-Induced Laryngeal Obstruction signature detected via ultra-low noise micro-electromechanical (MEMS) microphone amplitude (dB) prior to and during EILO. EILO signature detected via accelerometer (g, where g represents the gravitational acceleration of 9.8 m/s2) prior to and during EILO

Baseline and Perioprocedural
Treadmill testing
기간: Baseline and Perioprocedural

Breathing frequency (breaths per minute)

Baseline and Perioprocedural
Treadmill testing
기간: Baseline

Tidal volume (Liters)

Baseline
Treadmill testing
기간: Breath-by-breath baseline and Perioprocedural

Ventilation (Liters/minute)

Breath-by-breath baseline and Perioprocedural
Treadmill testing
기간: Baseline and Periprocedural

Partial pressure of arterial carbon dioxide estimated from end-tidal partial pressure of carbon dioxide; PetCO2) (mmHg)

Baseline and Periprocedural
MRI Upper Airway Size
기간: Baseline

Length (mm), width (mm), and cross-sectional area (mm2) of oropharynx, supraglottis, glottis, immediate subglottis.

Baseline
Upper Airway Aerodynamics
기간: Baseline and Periprocedural

pressure (Pa) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural
Upper Airway Aerodynamics
기간: Baseline and Periprocedural

volume flow rate (l/s) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural
Upper Airway Aerodynamics
기간: Baseline and Periprocedural

flow velocities (m/s) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural

2차 결과 측정

결과 측정
측정값 설명
기간
Self-rating of dyspnea
기간: Baseline

Participants will rate breathing intensity and breathing unpleasantness on a Visual Analog Scale of 0 to 100mm, where 0 indicates not at all and 100 indicates maximal imaginable intensity/unpleasantness.

Baseline
Profile of Mood States (POMS)
기간: Baseline

The POMS will be used to evaluate the participants' mood and to better understand how the emotional state relates to physical responses during testing. The POMS measures different aspects of mood on a 5-point Likert scale from 0 (not at all) to 4 (extremely).

Baseline
Menstrual Screening Questionnaire
기간: Baseline

Female participants will complete a screening questionnaire about menstruation history and use of hormonal birth control which will be used to evaluate the relationship between EILO and menstruation.

Baseline
Pittsburgh Sleep Quality Index (PSQI)
기간: Baseline

The PSQI will be used to evaluate the relationship between sleep and exercise. Total PSQI scores range from 0 to 21 with lower scores indicating better sleep quality.

Baseline
International Physical Activity Questionnaire (IPAQ)
기간: Baseline

Participants will complete the IPAQ which collects information on the frequency and duration of physical activities.

Baseline

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Rita Patel, Indiana University

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 8월 12일

기본 완료 (추정된)

2032년 1월 20일

연구 완료 (추정된)

2032년 1월 20일

연구 등록 날짜

최초 제출

2026년 1월 13일

QC 기준을 충족하는 최초 제출

2026년 2월 11일

처음 게시됨 (실제)

2026년 2월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 4일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 29009
  • R01DC023381 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

The data will be available indefinitely, as per NIH's Data Management and Sharing Policy to maximize the appropriate sharing of scientific data.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액
  • ANALYTIC_CODE
  • CSR

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

예

미국 FDA 규제 기기 제품 연구

예

미국에서 제조되어 미국에서 수출되는 제품

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .